...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** BETonMACE Phase 3 Cardio Outcomes Trial for Apabetalone Has Reached its Targeted 250 MACE Events ** Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Message: Booyah ! I told you all!!

 "Please stop and be objective"

Lol. The irony. Objectivity is based on facts, which many of your claims, EagleEyeCap, of late are completely devoid of. 


New Message
Please login to post a reply